跳至主要内容
临床试验/JPRN-UMIN000030679
JPRN-UMIN000030679已完成未知

Safety assessment study on excessive intake of test supplement - Safety assessment study on excessive intake of test supplement

Soiken Inc.0 个研究点目标入组 24 人开始时间: 2018年1月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Soiken Inc.
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Subjects who have a history or present serious disease such hepatic disorder, cardiovascular disorder, respiratory disorder, endocrine disorder, metabolic disorder. 2.Subjects who have a disease requiring regular medication. 3.Subjects who are at risk of developing allergy in relation to the test supplement 4.Subjects who are participating in other clinical trials when start of the examination period 5.Subjects who intend to become pregnant or lactating 6.Subjects who donated 200 mL in the past month or more than 400 mL within 3 months (blood donation etc.) 7.Subjects who are judged as unsuitable for the study by the principal doctor

研究者

发起方
Soiken Inc.

相似试验